These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21899726)

  • 1. Sorting through the many opportunities for melanoma therapy.
    Herlyn M; Villanueva J
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):975-7. PubMed ID: 21899726
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal treatment selection for patients with metastatic melanoma.
    Sullivan RJ
    Oncology (Williston Park); 2015 Feb; 29(2):139-41. PubMed ID: 25683836
    [No Abstract]   [Full Text] [Related]  

  • 3. Have we won the race in the treatment of advanced melanoma-or are we just learning to walk?
    Luke JJ
    Oncology (Williston Park); 2015 Feb; 29(2):136, 138-9. PubMed ID: 25683835
    [No Abstract]   [Full Text] [Related]  

  • 4. An antibody-drug conjugate targeting the endothelin B receptor for the treatment of melanoma.
    Asundi J; Reed C; Arca J; McCutcheon K; Ferrando R; Clark S; Luis E; Tien J; Firestein R; Polakis P
    Clin Cancer Res; 2011 Mar; 17(5):965-75. PubMed ID: 21245091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for cutaneous melanoma.
    Nathan FE; Mastrangelo MJ
    Semin Oncol; 1995 Dec; 22(6):647-61. PubMed ID: 8539640
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of a photoactivated rhodium complex in melanoma.
    Kim MR; Morrison H; Mohammed SI
    Anticancer Drugs; 2011 Oct; 22(9):896-904. PubMed ID: 21642837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic targets in melanoma.
    Martí RM; Sorolla A; Yeramian A
    Actas Dermosifiliogr; 2012 Sep; 103(7):579-90. PubMed ID: 22261672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple molecular target approach to selective melanoma cytotoxicity.
    Skibo EB; Jamil A; Austin B; Hansen D; Ghodousi A
    Org Biomol Chem; 2010 Apr; 8(7):1577-87. PubMed ID: 20237668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [To outwit melanoma with its own tricks].
    Bischoff A
    MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of targeted therapy and immunotherapy in melanoma.
    Blank CU; Hooijkaas AI; Haanen JB; Schumacher TN
    Cancer Immunol Immunother; 2011 Oct; 60(10):1359-71. PubMed ID: 21847631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular markers of response to treatment for melanoma.
    Sznol M
    Cancer J; 2011; 17(2):127-33. PubMed ID: 21427556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond.
    Sullivan RJ; Atkins MB
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1205-16. PubMed ID: 20687784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and planned multicenter trials for patients with primary or metastatic melanoma.
    Sondak VK; Han D; Deneve J; Kudchadkar R
    J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models.
    Rapp M; Maurizis JC; Papon J; Labarre P; Wu TD; Croisy A; Guerquin-Kern JL; Madelmont JC; Mounetou E
    J Pharmacol Exp Ther; 2008 Jul; 326(1):171-7. PubMed ID: 18411412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic treatment of metastatic melanoma: new approaches.
    Hamid O; Boasberg PD; Rosenthal K; O'Day SJ
    J Surg Oncol; 2011 Sep; 104(4):425-9. PubMed ID: 21858838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The malignant melanoma landscape.
    Webster RM; Mentzer SE
    Nat Rev Drug Discov; 2014 Jul; 13(7):491-2. PubMed ID: 24981356
    [No Abstract]   [Full Text] [Related]  

  • 18. New therapeutic options in systemic treatment of advanced cutaneous melanoma.
    Mackiewicz-Wysocka M; Zolnierek J; Wysocki PJ
    Expert Opin Investig Drugs; 2013 Feb; 22(2):181-90. PubMed ID: 23215674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma.
    Benson C; Gore ME
    Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted treatment for melanoma.
    Monga M; Abraham J
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1113-5. PubMed ID: 23098110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.